Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
16 Jul 2025
Global Psoriatic Arthritis Guidelines Reveal Gaps
A new comparative analysis of international guidelines for psoriatic arthritis (PsA) management reveals key divergences in treatment strategies across leading rheumatology societies, underscoring ongoing challenges in global consensus despite shared therapeutic goals.
16 Jul 2025
Real-World Outcomes Support Secukinumab in Spondylarthritis
Six-year data from Poland’s leading biologic treatment center highlight the real-world success of secukinumab in spondylarthritis, with high response and retention rates.
16 Jul 2025
New Mortality Risk Model for Severe Drug Reaction
A new international study has developed and validated prognostic models using novel inflammatory markers to predict in-hospital mortality in patients with drug reaction with eosinophilia and systemic symptoms (DRESS), a rare but life-threatening hypersensitivity reaction.
5 minutes with... Graham Clark, CEO, Phastar
Graham Clark, CEO, Phastar, explores the current state of play in clinical research, the future of AI in the field and values-based business.
16 Jul 2025
New Genetic Score May Guide Leukaemia Treatment
A large new study has confirmed the clinical relevance of a pharmacogenomic score that could help tailor leukaemia treatment and address persistent racial disparities in outcomes.
16 Jul 2025
Emerging Treatments for Hidradenitis Suppurativa
As HS remains underdiagnosed and undertreated, findings such as these could help support more informed, patient-specific therapeutic decisions moving forward.
16 Jul 2025
Unseen burden of CIDP
Explore the current disease burden and possible treatment pathways of chronic inflammatory demyelinating polyneuropathy (CIDP) in this interactive infographic.
16 Jul 2025
Study Reveals Women Digest Oats Better Than Milk
A new in vitro study reveals sex-specific differences in the digestion of milk and oat-based drinks, offering important insights for personalized nutrition and food innovation.
16 Jul 2025
Fast Track Immunity - TBE and rabies
Fast-Track Immunity: Rapid immune protection through advanced vaccination strategies for Tick-borne Encephalitis vaccination and Abbreviated rabies PrEP schedules
15 Jul 2025
Is Faster Cancer Treatment Finally Within Reach? Understanding Subcutaneous Immunotherapy
Subcutaneous (SC) delivery of immunotherapies for solid tumors has emerged as a potentially transformative approach to cancer treatment, promising comparable clinical efficacy to intravenous (IV) therapies while significantly reducing treatment time and burden on healthcare systems.
←
1
2
3
4
5
6
7
8
9
…
1,224
1,225
1,226
→
We’ve noticed you’re accessing
from
North/South America.
View
View